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ABSTRACT
Serotonin’s involvement in many physiological processes including anxiety, 
stress, compulsivity, and mood has been speculated for decades. Insufficient 
progress in our understanding of serotonin chemistry is due to the lack of 
effective tools to selectively measure this neurotransmitter on a 
neurotransmission-relevant time scale in vivo. An analytical technique for 
serotonin measurements, fast-scan cyclic voltammetry (FSCV), was pioneered in 
the last decade in anesthetized rodents and is beginning to shed light on the 
complexity of serotonergic activity on a sub-second timescale. Complementary, 
more recent technological innovations have enabled ambient neurotransmitter 
levels to be determined every few seconds using a method called fast-scan 
controlled-adsorption voltammetry (FSCAV). Chapter 1 of this thesis is an 
introduction to the work. In Chapter 2, the traditional experimental challenges that 
have thus far limited serotonin measurements are discussed and FSCV is 
highlighted as a technology that overcomes these difficulties.  In Chapter 3, a 
simplified FSCAV module, which can be easily constructed by non-experts in 
electronics, is presented. This component is composed of two light-emitting 
diodes (LEDs). Together, this thesis showcases the design and application of 
improved electrochemical tools for in vivo analysis of neurotransmitters in the 
context of psychiatric disorders.  
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CHAPTER 1 
INTRODUCTION 
  
 2 
1.1 The Serotonergic System 
The neurotransmitter serotonin crucially modulates the activity of many neuronal 
pathways and is involved in a plethora of physiological processes controlling 
mood, emotion, and social behavior (Mann 1999; Edwards & Kravitz 1997). 
Previous studies suggest that deficits in serotonin neurotransmission are a factor 
in several psychiatric disorders including depression, anxiety, eating disorders, 
and obsessive-compulsive disorder (Muller & Jacobs, 2009; Lucki 1998). 
Consequently, selective-serotonin reuptake inhibitors (SSRIs) were developed to 
increase extracellular serotonin levels by inhibiting serotonin transporters and 
hindering the reuptake of serotonin back into the cell (Fuller, Perry, Molloy, 1974; 
Fuller & Wong, 1977). SSRIs are the most commonly prescribed 
pharmacological treatment for the above-mentioned disorders, however clinical 
success is inconsistent. The irregularity in therapeutic relief is yet to be 
understood due to the lack of suitable tools to selectively probe this elusive 
neurochemical on a neurotransmission-relevant timescale in vivo.  
Sampling techniques, such as microdialysis, have provided the bulk of our 
current comprehension of serotonin dynamics (Miyazaki K.W., Miyazaki, K., & 
Doya, 2011; Fuller 1994), however microdialysis’ temporal resolution and large 
probe size has prevented a deeper understanding of the real-time influence of 
serotonin on brain circuitry (Jaquins-Gerstl & Michael, 2015). In 2009, Hashemi 
et al. pioneered rapid (10 ms) measurements of in vivo stimulated serotonin 
release and reuptake using fast-scan cyclic voltammetry (FSCV) in the rat 
substantia nigra pars reticula (SNR). Using FSCV technology, our lab has just 
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begun to shed light on in vivo serotonin dynamics and the role serotonin plays in 
psychiatric disorders. 
 
1.2  The Scope of the Thesis 
In this thesis, I first describe the traditional challenges of measuring serotonin in 
vivo and introduce FSCV as an electroanalytical technique that can overcome 
these difficulties. Next, fast-scan controlled-adsorption voltammetry (FSCAV) is 
underlined as a cutting-edge technology that allows for the rapid measurement of 
ambient neurotransmitter concentrations (Chapter 2). Finally, the development 
and characterization of a simplified component for FSCAV instrumentation is 
reported (Chapter 3). The outline of this thesis is described below: 
Chapter 1: Introduction 
Chapter 2: This chapter focuses on the historical difficulties of selectively 
targeting the serotonergic system for measurement. Next, FSCV is highlighted as 
an emerging method to allow for sub-second detection of phasic serotonin 
release and reuptake in particular brain regions of rodents. Furthermore, the 
most recent technological advancement for the measurement of ambient 
neurotransmitter concentrations using FSCAV are discussed.  
Chapter 3: In this chapter, we develop and characterize a simplified component 
termed the LED circuit for FSCAV measurements. The LED circuit was designed 
to be able to be constructed by a novice in electronics, enabling ambient 
neurotransmitter measurements to be performed by a larger community. In vitro 
and in vivo analyses were performed and found to be in good agreement 
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between the novel LED circuit and the original switch utilized in previous FSCAV 
reports.  
Chapter 4: The final chapter summarizes the conclusions of this work and 
considers the future directions of this research.  
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CHAPTER 2 
REAL-TIME RESOLUTION MEASUREMENT OF SEROTONIN IN 
RODENTS1
                                                          
1 Robke, R., Parthasarathy, A., Willuhn, I., & Hashemi, P. To be submitted to the 
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Investigations of the serotonin system started upon discovery of this messenger 
in the 1950s. These studies unearthed critical roles for serotonin both in the brain 
and in the body’s periphery. However, much remains to be determined about the 
precise functions of serotonin, in particular serotonin neurotransmission in the 
brain. Serotonin is thought to be involved in the neurochemical coding of 
numerous physiological processes underlying aggression, anxiety, appetite, 
impulsivity and compulsivity, mood, social behavior, and stress (Muller & Jacobs, 
2009). Serotonin’s involvement in these disorders and others has been assumed 
for decades; the cause of the ongoing speculation and insufficient progress in our 
understanding, however, is primarily the lack of effective tools to selectively 
probe this elusive neurotransmitter on a neurotransmission-relevant time scale in 
vivo. Sampling techniques, such as microdialysis, have enriched our current 
comprehension of serotonin dynamics significantly (Miyazaki K.W. et al., 2011; 
Fuller 1994). However, in general, microdialysis sampling methods lack the 
temporal resolution to effectively clarify serotonin function in vivo (Nandi & Lunte, 
2009). Serotonin-relevant behaviors depend on environmental cues and specific 
actions, therefore high temporal resolution is necessary to unravel the precision 
function of serotonin in behavior (Anastasio et al., 2013; Burmeister, Lungren, 
Kirschner, & Neisewander, 2004). Additionally, there are ongoing discussions 
about the integrity of the chemical data obtained given the high magnitude of 
brain tissue damage caused by large sampling probes (Borland, Shi, Yang, & 
Michael, 2005; Jaquins-Gerstl & Michael, 2015). In contrast, a more niche 
analytical method, fast-scan cyclic voltammetry (FSCV), allows scientists to 
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identify and quantify rapid neurotransmission (sometimes referred to as “phasic”) 
on a sub-second time scale using microelectrodes that cause minimal tissue 
damage (Phillips, Robinson, Stuber, Carelli, & Wightman, 2003; Clark et al., 
2010). 
FSCV has been extensively used to study dopamine neurotransmission 
on an advanced behavioral platform, primarily elucidating dopamine’s roles in 
learning and motivation (e.g., Hamid et al., 2016; Day, Roitman, Wightman, & 
Carelli, 2007; Willuhn, Burgeno, Groblewski, Phillips, 2014). More recently, 
serotonin FSCV was pioneered in anesthetized rodents and is just beginning to 
shed light on the complexity and impact of serotonergic activity (Hashemi, 
Dankoski, Petrovic, Keithley, & Wightman, 2009). Complementary, an even more 
recent cutting-edge technological evolution enables the measurement of ambient 
(sometimes referred to as “tonic”) extracellular neurotransmitter concentration 
with FSCV technology using a method called fast-scan controlled-adsorption 
voltammetry (FSCAV) (Atcherley, Laude, Parent & Heien, 2013). Importantly, 
FSCV and FSCAV can be combined at a single sensor to measure both “phasic” 
and “tonic” serotonin concentrations in vivo.  
In this chapter, the traditional experimental challenges of measuring 
phasic serotonin will be outlined and FSCV will be highlighted as a method that 
can overcome these difficulties. The status quo of applying FSCV for 
understanding serotonin function in vivo will be highlighted and the existing gaps 
in our knowledge will be identified. Suggestions for filling these gaps will be 
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offered to better shape the fundamental understanding of serotonin’s roles in the 
brain. 
2.1 Rapid Measurement of Serotonin In Vivo 
It is substantially more difficult to make in vivo measurements of serotonin, 
compared to dopamine, a related amine neuromodulator because many 
regulatory systems work simultaneously to maintain serotonin homeostasis. The 
result of this strict regulation is a relatively low extracellular concentration of this 
signaling molecule in comparison to dopamine. The reasons for this strict 
homeostasis is multi-tiered, but at the most basic tier, it is likely due to the 
immediately toxic effects of high extracellular serotonin levels that can lead to a 
fatal disorder termed serotonin syndrome. The profound level of regulation 
required to maintain serotonin transmission has thus rendered measurements 
challenging and, therefore, this modulator’s involvement in neurological and 
psychiatric disorders remained elusive. 
In the following section, we will discuss the challenges of measuring 
serotonin dynamics in vivo as a function of (1) the contribution of the 
concentrated anatomical clustering of serotonin cell bodies in the base of the 
mammalian brain, (2) the dynamics of the extracellular presence of the 
transmitter, (3) tight regulation at a number of levels, and (4) the detrimental 
effects of serotonin’s metabolites on implanted microelectrodes (not problematic 
for microdialysis). We speculate that, in the past, these circumstantial factors 
have hampered the pace of serotonin research as compared to research 
targeting dopamine neurotransmission. Finally, we highlight exciting innovative 
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advancements that have the potential to significantly increase the pace of 
serotonin research. 
2.1a Neuroanatomy of the Serotonin System 
The serotonin network in the central nervous system of mammals originates in 
the raphe nuclei, a cluster of brain nuclei with cell groups distributed along the 
midline of the midbrain and brainstem (Hornung, 2003). The rostral group of 
serotonin neurons in the raphe nuclei project widely to forebrain structures like 
the amygdala, the hippocampus and all regions of the neocortex and striatum. 
Specifically in the cortex, the fibres innervate the neocortex via the lateral 
hypothalamus and the median forebrain bundle (MFB). From the MFB, the fibres 
project to the frontal cortex and then traverse posteriorly to innervate parietal, 
temporal, and occipital cortices. This widespread innervation of the brain 
provides an indication for serotonin’s global function modulating a variety of 
fundamentally important processes including sleep and arousal processes, 
executive function (mediated by the prefrontal cortex), behavioral control of mood 
and emotion, social behavior, impulsivity, compulsivity, and learning and memory 
(Muller & Jacobs, 2009). Given this broad presence, in addition to the analytical 
challenges described above, it has been difficult to identify more precise roles for 
serotonin. 
The dorsal raphe nucleus (DRN) is the principal area of cell bodies 
containing serotonin that widely innervates the brain. The DRN is embedded in a 
central location on the mid-line, directly under the lambda fissure of the rodent 
skull. The DRN is located underneath a dense network of core vasculature and 
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the cerebral aqueduct (Paxinos & Watson, 2007). This elusive DRN location 
means that targeting serotonin’s main hub is experimentally extremely 
challenging due to risk of substantial damage of the surrounding vasculature and 
diffusion of infused drugs or viruses into the neighboring aqueduct. It is important 
to directly access serotonergic neurons because the detection of phasic 
serotonin is still dependent on stimulated release. As of now, there are no known 
behaviors that reliably evoke serotonin release. Approaches intended to 
overcome this complication have been to target the DRN at an angle instead of 
vertically from the top of the skull (Figure 2.1A) (Kirby, Rice, & Valentina, 2000; 
Correia et al., 2017), although this strategy introduces many errors, and thus 
considerably lowering success rate. Another approach is to target the MFB for 
the manipulation of serotonin release, which greatly increases success rate 
(Hashemi, Dankoski, Wood, Ambrose, & Wightman, 2011), however, at the cost 
of markedly diminished selectivity of target structures by electrical stimulation. 
2.1b Heterogeneity and Co-Localization with Other Neurotransmitters in the   
DRN 
The DRN is neuro-chemically not a homogeneous structure and is innervated by 
neurons containing glutamate, GABA, and dopamine (Figure 2.1B) (Charara & 
Parent, 1998; Qi et al., 2014; Calizo et al., 2011; Challis et al., 2013; Celada et 
al., 2001; Weissbourd et al., 2014). In the DRN and throughout other areas of the 
brain, histamine-containing vesicles are often found to be co-localized with 
serotonin, and is thought to modulate serotonin transmission via inhibitory H3 
hetero-receptors on serotonin-containing neuron terminals (Chase & Murphy, 
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1973; Russell, Henry, Phebus, & Clemens, 1990; Brown, Stevens, & Haas, 2001; 
Haas, Sergeeva, & Selbach, 2008; Threlfell et al. 2004). Due to this high co-
localization of numerous neurotransmitters in the DRN, it has been challenging to 
selectively target serotonergic neurons and to clarify their role in behavior thus 
far.  
In order to target serotonin neurons selectively on a genetic platform, and 
thereby more selectively stimulate serotonin release for phasic detection, it was 
attempted to identify and capitalize on molecular markers to circumvent regional 
neuronal heterogeneity. However, previously identified molecular markers that 
were considered to be selective for serotonin neurons, ETS domain factor Pet-1 
and the serotonin transporter (SERT), have later been shown to be present in 
glutamate and other neuronal systems (Liu et al., 2014; Hainer et al., 2015). This 
lack of specificity has restricted the development of reliable transgenic rodent cre 
lines for optogenetic and chemogenetic targeting of serotonin neurons and 
represent yet another reason why our understanding of serotonin’s influence on 
neuronal circuits has fallen behind compared to other neurotransmitter systems 
in which novel genetic-based techniques are reliably employed (Hersman et al., 
2017; Tye et al., 2013). Currently, tryptophan hydroxylase 2 (TPH2), the enzyme 
which catalyzes the first rate-limiting step of serotonin synthesis in the central 
nervous system, has the potential to become the first valid platform for selective 
genetic modification of the serotonin system due to its exclusive presence in 
serotonergic producing cells (Zill et al., 2007; Sakowski et al., 2006; Walther & 
Bader, 2003). 
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2.1c The Complexity of Serotonin Neurotransmission 
The coordinated effort by many, simultaneous systems to tightly regulate 
extracellular serotonin levels presents challenges for detection (vide supra). The 
likely consequence of this are endogenous extracellular serotonin concentrations 
that are much lower than dopamine levels (Figure 2.1C) (Shen et al., 2004). To 
date, 15 serotonergic receptors have been identified that precisely and rapidly 
control serotonin (Nautiyal & Hen, 2017; Jennings, 2013). In addition, multiple 
mechanisms influence serotonin reuptake including promiscuous reuptake of 
serotonin by other monoamine transporters (e.g. dopamine transporters (DATs), 
norepinephrine transporters (NETs) and organic cation transporters (OCTs)), 
other than SERTs (Baganz et al., 2008; Daws, Toney, Gerhardt, & Frazer, 1998). 
Further highlighting the sheer intracy of this system, significant control of 
serotonin reuptake is implemented by serotonin autoreceptors that are G-protein 
coupled to SERTs. (Montañez, Munn, Owens, Horton, & Daws, 2014; Murphy et 
al., 2003). To even further obstruct measurements, serotonin metabolites of 
similar chemical structure can be nearly 500 times more concentrated than 
serotonin itself (Hashemi et al., 2009), indicating a rapid rate of metabolism. Not 
only does this fast metabolism reduce the time during which serotonin is 
detectable, some metabolites have been shown to dramatically degrade the 
integrity of microelectrode detection probes (Hashemi et al., 2009). Together, 
these circumstances complicate both the measurement and understanding of 
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serotonin in vivo and ultimately how serotonergic activity corresponds to 
behavior. 
2.1d Measurement of Serotonin In Vivo 
Active neurochemical signal delivery relies on sub-second chemical exchange. 
Thus, to define serotonin neurotransmission, high temporal-resolution 
measurement is critical. Traditional microdialysis has formed our current 
apprehension of overall serotonergic activity (for example: Yang, Thompson, 
McIntosh, Altieri, & Andrews, 2013; Volle et al, 2018). Microdialysis has low 
detection limits when coupled to efficient analytical techniques for separation, 
detection, and quantification of analytes (e.g. ultrahigh-performance liquid 
chromatograph and electrochemical detection) (Liu et al., 2010). However, 
disadvantages such as temporal resolution (> 1 minute) and damage of tissue 
surrounding the large probe (approximately 200 um) have created a large body 
of contradictory results (Chefer, Thompson, Zapata, & Shippenberg, 2009; 
Jaquins-Gerstl & Michael, 2015). Consequently, measurement tools for this 
analyte that operate at high time resolution with minimal tissue damage are 
highly desired. Notably, an electrochemical technique called chronoamperometry 
has been employed previously by Daws and colleagues to explore SERT 
mechanisms under varying experimental conditions (e.g. genetically-modified 
animal models and pharmacological manipulations) primarily in the hippocampus 
(Montanez et al., 2014; France et al., 2009; Daws et al., 2005). These 
experiments have greatly improved our understanding of the SERTs and their 
rate of serotonin clearance. However, this technique typically requires exogenous 
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application of serotonin (Daws, Toney, Davis, Gerhardt, & Frazer, 1997) and the 
external source of serotonin has been thought to cause rapid physiological 
changes in SERT expression (Daws & Toney, 2007). 
FSCV has become one of the most powerful analytical techniques to study 
neurotransmitter release and reuptake in vivo due to its small probe size (6 um) 
and high selectivity, sensitivity (nM), and temporal resolution (10 Hz). Since the 
development of FSCV by Ralph Adams in the 1980’s, numerous seminal 
discoveries have been made on dopamine’s role in learning and motivation using 
this technique (e.g. Phillips et al., 2003; Flagel et al., 2011; Cheer et al., 2007). 
 More recently, serotonin FSCV measurements have been established in 
anesthetized rodents and are just beginning to unearth the dynamics and the 
sheer complexity of serotonin’s in vivo actions. 
Figure 2.1. Challenges of measuring serotonin. (A) Histology from the lab 
showing the experimental targeting of the dorsal raphe nucleus at a 30-degree 
angle. (B) The dorsal raphe nucleus is non-homogenous, shown by the 
heterogeneous innervation of the ventral tegmental area (VTA). Data adapted 
from Qi et al, 2014. (C) Neurotransmitter content in the whole rat brain (adapted 
from Zhu et al., 2011) and specific regions. *data obtained from the lab; 
unpublished results from Botterblom & Feenstra. 
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In the next section, general electrochemistry principles governing the 
dynamics of sub-second FSCV neurotransmitter sampling are described. The 
contributions of this technique to furthering our understanding of in vivo serotonin 
fluctuations are highlighted and novel frontiers in other electrochemical 
methodologies are explored. 
2.2 FSCV: General Principles 
  FSCV is an analytical tool that takes advantage of thermodynamic and 
electrochemical phenomena to govern subsecond measurements. Small, 
positively charged ions such as dopamine and serotonin are attracted to a 
negatively charged carbon-fiber microelectrode (CFM) surface during a short 
holding period (typically 100 ms). Then an analyte specific waveform, which is 
tailored to induce electron transfer via oxidation and reduction of the ion, is 
applied to the CFM. The oxidation and reduction occur at discrete potentials and 
are measured as current vs. potential to obtain a cyclic voltammogram (CV). The 
CV acts as an electrochemical “stamp” and is used to qualify and quantify the 
analyte (Phillips & Wightman, 2003). 
  Besides its advantages in time resolution and small probe size, selectivity 
can be a concern in any analytical measurement. In FSCV, two primary intrinsic 
chemical properties can be exploited to provide selectivity; analyte electron 
transfer kinetics and the charge on the ion. Depending on the ion of interest a 
combination of approaches can be taken that take into account charge and 
electron transfer kinetics of the analyte of interest vs. those of interferences. This 
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is illustrated below by using dopamine and serotonin detection, respectively, as 
examples. 
2.2a Selectivity of Dopamine Detection 
For FSCV dopamine measurements, it is well known that ascorbic acid (AA) is 
the primary interferent. However, the high ambient levels of ascorbic acid in the 
brain (McIlwain, Thomas, & Bell, 1956; Schenk, Miller, Gaddis, & Adams, 1982) 
should not interfere with the signal because FSCV is background subtracted. 
Nonetheless, AA may reduce the sensitivity of the electrode to dopamine if 
adsorption sites on the CFM are blocked by AA. More significantly perhaps is 
that AA is released upon glutamate reuptake (Cammack, Ghasemzadeh, & 
Adams, 1991) since FSCV stimulations will release both dopamine and 
glutamate. Thus, AA is likely to be transiently released during FSCV file 
collection. As discussed above, selectivity can be garnered by utilizing 
differences in electron transfer kinetics and ionic charge. In solution, ascorbic 
acid is negatively charged and dopamine is positivity charged, and the electron 
transfer kinetics of AA oxidation are significantly slower vs. dopamine oxidation 
(Wightman, May, & Michael, 1988). Therefore, if between scans the electrode is 
held at a negative potential and a fast enough scan rate is applied, then AA is 
repelled during scans and does not have an opportunity to transfer electrons to 
the CFM during the scan. This effect can be potentiated if the CFM surface is 
‘activated’ prior to analysis. Activation refers to oxidation of the surface by heat, 
electrochemistry or chemical treatments (Heien, Phillips, Stuber, Seipel, & 
Wightman, 2003; Strand & Venton, 2008). This activation procedure deposits a 
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high density of negatively charged oxygen moieties on the electrode surface, 
thus increases the extent of AA repulsion and actually facilitates dopamine 
preconcentration. Surface oxidation has a further advantage when performed 
electrochemically during each scan (i.e. scanning up to 1.3 V). At 1.3V, carbon 
itself is oxidized and a monolayer of carbon is lost from the CFM surface, 
essentially providing a fresh electrode for the next measurement (preventing 
irreversible fouling) (Takmakov et al., 2010; Mitchell, Dunaway, McCarty, & 
Sombers, 2017). 
2.2b Selectivity of Serotonin Detection 
The biggest challenge for selective serotonin measurements is interference by 
dopamine given the mutual presence of both these neuromodulators in many 
parts of the brain and their similar chemical properties. The transfer kinetics of 
serotonin electro-oxidation are more rapid vs. dopamine, consequently sensitivity 
to dopamine can be reduced by increasing scan rate to 1000 V s-1 (Figure 2.2A). 
An additional phenomenon that helps here is that the serotonin adsorption 
equilibrium onto the CFM is more favorable than dopamine’s adsorption. This 
effect means that the resting potential between scans can be kept at a positive 
potential which, in addition to scanning faster, significantly diminishes the FSCV 
response to dopamine. The main metabolite of serotonin, 5-Hydroxyindoleacetic 
acid (5-HIAA) is not thought to be a significant interference since there is no 
evidence that it is transiently released, however 5-HIAA is problematic for 
electrode fouling (Hashemi et al., 2009). Electrode fouling is the accumulation of 
undesired material on the carbon-fiber surface that is detrimental to the 
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electrode’s function, therefore adjustments in the FSCV detection scheme is 
necessary to exclude the influence of this metabolite on the CFM. These are 
discussed in the following section. 
2.3 Serotonin FSCV  
The first report of serotonin FSCV in vivo was an experiment in which dopamine 
was depleted from dopamine neuron terminals in the striatum via inhibition of L-
aromatic acid decarboxylase. These neurons were then loaded with serotonin by 
a means of tryptophan loading, promoting electrically evoked serotonin release 
(Stamford, Kruk, & Millar, 1990). This experiment, although elegant, was not 
indicative of the endogenous function of the serotonin system and the detection 
scheme utilized did not allow for discrimination between serotonin and dopamine. 
Additionally, serotonin electro-oxidation produces several intermediary 
monomers that rapidly polymerize on the electrode to create a ‘film’ covering the 
electrode. It is known that such an electrode ‘fouling’ significantly lowers 
electrode sensitivity. Later, the development of the ‘Jackson Waveform’ 
(Jackson, Dietz, & Wightman, 1995) significantly improved detection selectivity 
and electrode fouling: 
1) to distinguish between dopamine and serotonin 1000 V s-1 is utilized 
and the electrode is held at a positive resting potential 
2) to reduce the fouling effects of serotonin electro-polymerization on the 
CFM, the CFM is held at 0.2 V between scans, which abolishes the 
production of the the major electro-oxidation product. 1000 V s-1 also 
appears to reduce the production of these side products. 
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The Jackson waveform was subsequently utilized in tissue slice 
preparations to study serotonin dynamics in different brain regions and under 
SSRI treatment (Figure 2.2A) (Bunin & Wightman, 1998; Bunin, Prioleau, 
Mailman, & Wightman, 1998). The ‘Jackson Waveform’ was a breakthrough for 
real-time serotonin measurements, however, the waveform alone did not lead to 
successful measurements of evoked serotonin in vivo. In 2009, the reason for the 
lack of success for in vivo measurements was discovered by Hashemi et al., 
2009. One major difference between measurements in slice preparations and in 
vivo is the large ambient concentration of 5-HIAA in vivo. As previously 
mentioned, it is not likely that 5-HIAA would act as an interference, however, it is 
structurally very similar to serotonin and exerts similar fouling effects on the 
CFM. Given that it is 100-1000 times more concentrated in the extracellular 
space in vivo (in slice preparations it washes out), it rapidly and profoundly fouls 
the CFM as it is positioned in the brain in vivo. (Hashemi et al., 2009). In solution, 
5-HIAA is negatively charged while serotonin is positively charged. Thus, a new 
protocol was developed to selectively repel 5-HIAA by depositing Nafion onto the 
carbon fiber surface at an advantageous and controlled thickness (Brazell et al., 
1987; Rice & Nicholson, 1989). An unwanted side effect of Nafion application is 
that applied films that are too thick (1-3 um) lead to a significant decrease in 
electrode response times, whereas a layer that is too thin will not perform 
efficiently to repel 5-HIAA and fouling will occur (Nagy et al., 1985). The ideal 
thickness is about 300 – 350 um, as modeled and described in detail in Hashemi 
et al., 2009. After coating the CFM with Nafion, the microelectrode is nearly 200 
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times more sensitive to serotonin than 5-HIAA because of the pre-concentration 
of the positively charged serotonin ions trapped in the Nafion membrane, 
permitting in vivo measurements to be performed (Gerhardt, Oke, Nagy, 
Moghaddam & Adams, 1984; Hashemi et al., 2009). A scanning electron 
microscope (SEM) image of a Nafion-coated CFM is shown in Figure 2.2B. 
Nafion is not useful with waveforms that apply potentials > 1.0 V (i.e., dopamine 
waveform) due to the oxidation of the monolayer of the CFM during each scan as 
previously described which destabilize the Nafion layer. Potential disadvantages 
of the Nafion technique is the unequal coverage of the CFM and greater 
electrode variability, however strict adherence to the described electrodepositing 
procedure has can limit variability. 
 
 
Figure 2.2. Detection of serotonin 
using fast-scan cyclic voltammetry. 
(A) A serotonin-selective waveform is 
applied to the carbon-fiber 
microelectrode to promote the oxidation 
and reduction of serotonin, which is 
measured as current and is proportional 
to the serotonin molecules near the 
electrode. (B) Nafion-coated carbon-fiber 
microelectrodes are required to repel 
interfering metabolites (5-HIAA) and 
enhance serotonin sensitivity. Adapted 
with permission from Hashemi et al., 
2009. Copyright 2009 American 
Chemical Society. (C) Representative 
serotonin color plot and identifying cyclic 
voltammogram. 
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2.3a General Findings of Serotonin FSCV    
Although serotonin neurons project widely across the mammalian brain, it is not 
known whether serotonin signaling is uniform throughout the brain or whether 
regional specificity exists. It is generally postulated that deficits in serotonin 
neurotransmission can contribute to a number of psychiatric disorders including 
depression, anxiety, and obsessive-compulsive disorder (OCD). As such, 
selective-serotonin reuptake inhibitors (SSRIs) were developed in the late 70s 
(Fuller et al., 1974; Fuller, & Wong, 1977), which aim to increase extracellular 
serotonin levels by inhibiting SERTs. Clinical success of SSRIs in the above-
mentioned disorders (for which SSRI are one of the primary pharmacological 
treatments) is inconsistent. This irregularity in therapeutic relief may be due to 
regional differences in serotonin release and reuptake, whereby SSRI-induced 
global increases in extracellular serotonin availability and signaling may not be 
useful for therapeutic purposes. Alternatively, SSRI may have different regional 
effects on serotonin release and reuptake that is otherwise not distinguishable. 
Therefore, irregularity in therapeutic relief may be better understood by studying 
in vivo regional serotonin dynamics with FSCV. Finally, even in the case of 
regional uniformity, FSCV measurements may be necessary to uncover SSRI 
effects on the sub-second level.  Although serotonin FSCV is a young field, this 
section highlights the contributions this method is making to broadening our 
knowledge of serotonin dynamics in different brain regions. 
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Substantia Nigra, Pars Reticulata (SNR) 
To date, most FSCV measurements of serotonin have been performed in the 
SNR where serotonin terminals are the most concentrated of all brain regions 
(Palkovits, Brownstein, & Saavedra, 1974; Reubi & Emson, 1978). In 2009, the 
first paper reporting in vivo serotonin measurements in the SNR via DRN 
stimulation was published (Hashemi et al., 2009). As mentioned above, 
physically targeting the DRN is technically difficult and results in low success 
rates. In a follow up study, serotonin release in the SNR was observed by 
stimulating the medial forebrain bundle (MFB), an anatomically easier surgical 
target located anterior to the terminal release site. Due to the posterior position of 
the CFM with respect to the stimulating electrode, this suggested serotonin fibers 
could be retrogradely activated (Hashemi et al., 2011). 
The stimulation of MFB yields three distinct serotonin response profiles – 
fast, slow and hybrid based on their clearance slopes (Wood et al., 2014). As the 
name suggests, fast and slow response profiles show fast and slow serotonin 
clearance times (approximately 8s vs. 30s, respectively). The hybrid response 
profile is a mixture of the two and displays a fast decay to clear serotonin for a 
couple seconds then switches to a slow decay. Mathematical modelling of these 
responses revealed that two reuptake mechanisms – one high affinity, low 
efficiency system, termed Uptake 1 and mediated by SERTs and one low affinity, 
high efficiency system, facilitated by monoamine transporters other than SERTs, 
including DATs, NETs and OCTs. It is likely that at low extracellular 
concentrations, Uptake 1 by SERTs (high affinity, low efficiency) is efficient, 
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however at higher concentrations, serotonin may diffuse to other transporters 
(DATs, NETs, and OCTs) and be reuptaken by Uptake 2 mechanisms (low 
affinity, high efficiency). A common feature of all stimulated serotonin release is 
that the serotonin concentration ‘dips’ below the baseline after concentration 
levels return to baseline. Thus, an autoreceptor effect (7 seconds after the 
beginning of the stimulation) was incorporated into the model to account for this 
dip below baseline. Methiothepin, a non-selective serotonin receptor antagonist 
with a high affinity for serotonin autoreceptors, (Monachon, Burkhard, Jalfre, & 
Haefely, 1972) eliminates this dip below baseline, indicating that serotonin 
autoreceptors may act to reduce serotonin transmission within the time frame of 
the FSCV collection window (30s) (Barnes & Sharp, 1999; Wood et al., 2014). 
These findings support prior hypotheses on Uptake 1 and Uptake 2 in 
synaptosomes (Shaskan & Snyder, 1970; Daws, Koek, & Mitchell, 2013). 
Multiple reuptake mechanisms and the prolonged autoreceptor control of 
serotonin support the notion that serotonin a highly regulated system. 
SSRIs acutely act on the SERTs to inhibit the reuptake of serotonin, 
however, therapeutic relief in psychiatric patients may not be achieved until 
several weeks of chronic administration (Gelenberg & Chesen, 2000). After an 
acute dose of the SSRI Escitalopram (Lexapro; 10 mg kg-1 i.p.), FSCV 
measurements of serotonin showed immediate dynamic neurochemical changes 
through the rapidly augmented release of serotonin and gradual increase in 
clearance time (t1/2) over 2 hours (Wood & Hashemi, 2013). The t1/2 was 
positively correlated to an increasing dose of Escitalopram (1, 10, 100 mg kg-1) 
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while the amplitude was impacted the most by the middle dose (10 mg kg-1), 
similar to previous observations of DAT inhibition (Song et al., 2012). 
Alternatively, tissue slice preparations report only a modest increase of serotonin 
release (~10%), indicating that synaptic processes found in vivo additionally 
modulate SSRI mechanisms (Bunin & Wightman, 1998). Due to the increase in 
clearance time up to 120 minutes after an acute SSRI administration in vivo, it is 
highly likely that SSRIs cause dynamic physiological changes outside of their 
accepted mode of action for longer-term therapeutic benefits.  
Another important study compared the regulation of serotonin in the SNR 
to dopamine in the nucleus accumbens. Overall, it was found that serotonin 
transmission is most sensitive to uptake and metabolic mechanisms, while 
dopamine is dependent on synthesis and repackaging (Hashemi et al., 2012). 
The response profile of serotonin was shown to be much broader than dopamine, 
with measurable release occurring at a MFB stimulation depth of 7.0-10.0 mm 
below dura, compared to 8.0-9.0 mm for dopamine, supporting the known, wide 
innervation of the brain by serotonin.  
Hypothalamus 
The hypothalamus is an important structure, amongst others that comprise the 
limbic system and contains relatively high levels of serotonin (see Figure 2.1C; 
unpublished data from Feenstra & Botterblom). The premammillary nucleus (PM) 
is an interesting hypothalamic structure in that it contains high levels of both 
serotonin and histamine. Histamine had been thought to modulate serotonin 
transmission due to the presence of inhibitory H3 heteroreceptors on serotonin 
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terminals (Threlfell et al., 2004; Fink, Schlicker, Neise, Gothert, 1990). The effect 
of histamine on serotonin in the PM was studied in recent work via development 
of an FSCV method that simultaneously measures serotonin and histamine 
(Samaranayake et al., 2016). An anterior region of the MFB, containing fewer 
serotonin axons, (Nieuwenhuys, Geeraedts, & Veening, 1982) was stimulated. 
This stimulation evoked histamine, but not serotonin in the PM such that 
modulation of ambient, not evoked, serotonin could be investigated. A potent and 
rapid inhibition of serotonin was observed in response to histamine release. 
(Samaranayake et al., 2016). A dose response for thioperamide (2, 20, and 50 
mg kg-1), a histamine receptor (H3) antagonist, was carried out and the 
corresponding histaminergic and serotonergic responses were mathematically 
modeled. Overall, it was shown that the potent inhibition of serotonin by 
histamine in the PM is indeed mediated by H3 heteroreceptors on serotonergic 
neurons. This finding supports previous speculations that H3 receptors on 
serotonin terminals (Schlicker, Betz, & Gothert, 1988; Esbenshade et al., 2008) 
inhibit serotonin transmission (Threlfell et al., 2004). Due to the hypothalamus’ 
crucial role of regulating stress hormones, it is important to understand the 
neurochemical influence this region has on other neuromodulators, such as 
serotonin, to better understand how to better maintain stress levels and promote 
healthy individuals. 
Cortex 
The medial prefrontal cortex (mPFC) has a relatively high serotonin content and 
has been shown to have broad influence on cognitive control and modulating 
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social behavior (see Figure 2.1C; unpublished data from Botterblom & Feenstra) 
(Miller & Cohen, 2001). In 2018, two serotonergic release events corresponding 
to a single stimulation of the MFB was observed for the first time using FSCV in 
mice (West et al., 2018). The two responses were related to distinct reuptake 
profiles encompassing both Uptake 1 and 2 mechanisms, as previously 
described in the SNR. Through pharmacology, histology, and mathematics, it 
was found that different subsets of serotonin axons transverse the MFB and 
terminate in separate domains with distinct reuptake responses in separate 
cortical layers. This study supports the idea of intricacy of serotonin 
neurotransmission and presents evidence of a highly elaborate biochemical 
organization of serotonin in the mPFC. 
Serotonin FSCV measurements have also been made in layer 1 of the 
somatosensory cortex in mice, which is important for processing all sensory 
information (Jain, Qi, Collins, Kaas, 2008). This study revealed that serotonin 
neurons have a unique capability to undergo regrowth and gain of function 
following damage produced by a systemic amphetamine lesion or local stab 
lesion (Jin et al., 2016). Serotonin release was evoked by MFB stimulation and 
measured 1 week, 3 months, and 6 months after amphetamine treatment. No 
evoked serotonin release was recorded 1 week and 3 months post-lesion, 
however, by 6 months, a recovery in serotonin activity was apparent in 
comparison to controls (11.9 + 2.9 nM vs. 14.5 + 8.3 nM, respectively). 
Behavioral tests displayed similar results, with the recovery of their behavioral 
measures occurring only 6 months after an amphetamine lesion. Two-photon 
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microscopy images showed new serotonergic axon growth after 3 months, 
however, it was speculated that they may need further maturation to function. 
Overall, this study showed that a large percentage (>80%) of damaged serotonin 
axons are susceptible to new growth and recovery of functionality. Two possible 
explanations for this phenomena were given:  
1) since serotonergic axons rely on slow, diffuse volume transmission 
rather than fast-localized synaptic transmission (Hornung, 2003; 
DeFilipe & Jones, 1988), their regrowth is more relaxed and allows for 
an approximate former position to be adequate  
2) serotonin axonal growth cones fail to receive stop signals from the 
tissue matrix.  
Understanding the biochemical organization and corresponding serotonergic 
function of the cortex will lead to invaluable information on cortical plasticity and 
how to assemble neural connections that promote beneficial decisions and social 
behavior. 
Dorsal Raphe Nucleus (DRN) 
High-frequency electrical deep brain stimulation (DBS) is becoming a more 
common treatment for clinicians to alleviate depression and compulsive 
symptoms in psychiatric patients (Holtzheimer & Mayberg, 2011; Srejic et al. 
2014), however, the mechanisms underlying the effects of this approach is not 
well understood. A recent study by Srejic et al. showed that high frequency 
stimulation (HFS) of the mPFC resulted in a similar amplitude of serotonin 
release as a typical short train simulation, however, a more pronounced decay of 
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the extracellular serotonin concentration was evident, suggesting an 
enhancement of reuptake (Srejic, Wood, Zeqja, Hashemi, & Hutchinson, 2016). 
The enhancement of serotonin reuptake induced by HFS is speculated to be 
facilitated by an upregulation or modification of the affinity of SERTs (Zhu et al., 
2010; Baganz & Blakely, 2012). Additionally, this could be explained by activity-
dependent endocytosis, in which rapid endocytosis can be activated by intense 
stimulation (or exocytosis) when neurotransmitter recycling needs to be 
accelerated to restore vesicle storage (Klingauf, Kavalali, & Tsien, 1998; Sara, 
Mozhayeva, Liu, & Kavalali, 2002). These two potential explanations may serve 
as homeostatic synaptic mechanisms to maintain extracellular serotonin at 
control levels after HFS, which is in agreement with the previously observed tight 
regulation of serotonin in vivo (Hashemi et al., 2012). Due to presence of 
serotonergic cell bodies in the DRN, this region is of interest for the treatment of 
many psychiatric disorders by a means of globally impacting serotonergic 
circuitry throughout the brain. 
It is important to note that these findings would not be possible with a 
slower sampling technique such as microdialysis because of the required high-
temporal and spatial resolution that FSCV provides. Studies are ongoing to 
understand the biochemical arrangement of serotonin, how it is influenced by 
other neuromodulators, and why SSRIs are variable and delayed in their efficacy, 
in a bid to improve these therapies.  
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2.3b FSCV Disadvantages  
Although FSCV serotonin measurements provide invaluable information about 
serotonin release and reuptake under different experimental conditions and 
diseases, there are still substantial limitations for FSCV in investigations of 
serotonin. First, all of the aforementioned experiments have been conducted in 
anesthetized rodents. This has prevented a detailed understanding of serotonin 
activity linked to behaviorally relevant environmental stimuli and corresponding 
behavior. Second, FSCV is reliant on background subtraction thus electrical, 
chemical or behavioral stimuli are required to provoke release (Howell, Kuhr, 
Ensman, & Wightman, 1986). The fast-scan rates employed in FSCV lead to high 
“background” currents, thereby requiring the removal of the charging current to 
reveal small, faradaic currents produced by monoamines of low concentration 
and limiting FSCV measurements to changes in concentration. Third, electrical 
stimulation is non-selective and affects numerous neurotransmitters and 
neuronal targets. Furthermore, to evoke serotonin release, a powerful electrical 
stimulation must be employed (Hashemi et al., 2011; Robinson, Venton, Heien, & 
Wightman, 2003), which raises questions of physiological relevance and potential 
tissue damage upon repeated stimulation. Fourth, since FSCV relies on eliciting 
a change in concentration, ambient measurements could not traditionally be 
made to understand neurotransmitter basal activity. It is especially important to 
understand ambient, or tonic serotonin levels on a rapid timescale because 
serotonin axons are thought to primarily rely on slow, diffuse volume 
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transmission rather than fast, localized synaptic transmission (Hornung, 2003; 
DeFilipe & Jones, 1988). 
2.3c Novel Frontiers in Tool Development for the Investigation of Serotonin 
Novel technological advancements have been made to promote the 
understanding of serotonin in vivo. Developing optogenetic control of 
serotonergic neurons has become a major point of interest to combat the 
problem of non-selective electrical stimulation (McElligott, 2015). The first study 
that combined serotonergic FSCV measurements to optogenetic stimulation in 
vivo was performed in drosophila and showed that low-frequency stimulations of 
serotonin induce a steady-state response in comparison to high-frequency 
stimulation-induced peak responses (Xiao, Priyman, & Venton, 2014). Behavioral 
studies have also implemented optogenetic control of serotonin, primarily in 
mice. However, neurochemical readouts by FSCV have not been reported at this 
point. Some of these studies have indicated serotonin may be a key regulator of 
patience/waiting, due to the activation of serotonergic neurons corresponding to 
mice waiting longer for future rewards (Miyazaki K., Miyazaki K.W., & Doya, 
2012; Miyazaki K.W., Miyazak K., & Doya, 2012, 2014; Fronseca, Murakami, & 
Mainen, 2015). With the intention of translation to the clinics, a proof-of-principle 
study using a system called Wireless Instantaneous Neurotransmitter 
Concentration System (WINCS) was performed in DRN rat brain slices to 
measure serotonin with FSCV (Griessenauer et al., 2010). WINCS is a small, 
sterilizable, wireless data acquisition component designed in compliance with 
FDA standards for medical electrical device safety. Most recently, steps have 
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been taken to mathematically decipher in vivo signals, thought to contain a 
serotonergic component, obtained in Parkinson’s patients who received DBS 
electrodes and performed an investment task (Moran et al., 2018). 
Although all of these studies are advancing the methods in which 
serotonin can be measured and manipulated, there is still fundamentally a lack in 
our knowledge of the magnitude of ambient extracellular serotonin levels. A new 
technique, termed fast-scan controlled-adsorption voltammetry, has been 
recently developed to help fill this gap on a rapid time scale. 
2.4 Fast-Scan Controlled-Adsorption Voltammetry (FSCAV) 
FSCAV is a cutting-edge voltammetric technique that enables quantitative 
ambient in vivo neurotransmitter measurements (Atcherley, Wood, Parent, 
Hashemi & Heien, 2015). FSCAV reports basal neurotransmitter concentration 
over a 10 second period and can be performed in less than 20 seconds 
(Atcherley et al., 2013; Atcherley et al., 2015; Burrell, Atcherley, Heien, & Lipski, 
2015). An advantage of coupling FSCAV to existing FSCV systems is the 
production of a current versus voltage plot (CV), which, as described above is an 
essential process to identify analytes of interest (thereby also implicitly testing 
functionality of the electrode and its placement). Consequently, FSCAV 
experiments have thus far been initiated with FSCV to optimize the location of 
the CFM in a brain locale rich in the analyte of interest. 
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FSCAV measurements are performed in a three-step procedure. Step 1: 
an analyte-specific waveform is applied to the CFM at a high frequency (100 Hz) 
and scan rate (1200 V/s) to minimize adsorption to the CFM for 2 seconds, 
allowing for a response that is not governed by neurotransmitters (i.e. providing a 
background). Step 2: a constant potential (the analyte-specific holding potential) 
is then applied for 10 seconds to allow the neurotransmitter to pre-concentrate 
around the electrode and adsorb to the CFM, reaching a coverage density in 
equilibrium with the surroundings. Step 3: the same waveform used in step 1 is 
reapplied to the CFM and the adsorbed neurotransmitter is measured with FSCV 
in respect to the first two seconds of the data collection file (background). These 
steps can be visualized in Figure 2.3A.  The signal obtained from FSCAV has 
been shown to be dependent on both mass transfer and adsorption dynamics, 
which determine the time required to reach equilibrium in step 2 (Atcherley et al., 
2013). 
  
  
  
  
  
  
  
Figure 2.3. Overview of fast-scan controlled-adsorption voltammetry. (A) A 
visual representation of the three step process: 1) minimized adsorption; 2) 
equilibrium; 3) adsorption electrochemical measurement. The presence of the 
neurotransmitter near the carbon-fiber microelectrode, the potential application, 
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and surface-accumulated dopamine (rDA) are displayed top to bottom. (B) Color 
plot obtained from the measurement in step 3. (C) Representative current trace 
(red) 10 ms after the start of step 3 and representative integration limits used for 
data analysis. (D) A necessary post-implantation calibration plot. Reproduced 
from Atcherley et al., 2015 with permission from The Royal Society of Chemistry. 
In order to perform FSCAV, an additional piece of equipment, a digital 
switch, must be fabricated in-house and incorporated into existing FSCV 
systems. This switch employs an operational amplifier (op amp) coupled to a 
transistor-transistor logic (TTL), which enables the system to precisely and 
rapidly alter between applying a FSCV waveform and a constant potential from 
an external power source to the working electrode (Atcherley et al., 2013). 
FSCAV can easily be employed through FSCV software (WCCV or Demon 
Voltammetry, for example) using the stimulation settings. After file collection, 
data analysis is executed by integrating the first resulting CV of the analyte of 
interest during step 3. A representative color plot for the ambient measurement of 
dopamine is shown in Figure 2.3B. It is important to note that the first-
background subtracted CV becomes visible on the 2nd or 3rd scan after the 
waveform is re-applied following the constant potential of 10s, due to stray 
capacitance from the switching component when altering between the constant 
potential back to the waveform. To remove this large interfering background 
charge, convolution theory can be utilized (Oldham, 1986; Atcherley et al., 2013, 
2014). Due to electrode variability, integration limits need to be set intuitively in 
vivo due to the complex matrix of the brain and additional analytes that are 
present around the electrode (Cahill et al., 1996; Heien, Johnson, & Wightman, 
2004; Takmakov et al., 2010b). Most commonly, using current vs. time traces, 
the integration limits are set by placing both initial and final limits at the local 
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minima and encompassing the entire oxidation peak of the analyte (as seen in 
Figure 2.3C). The resulting area will be calculated as charge (pC) and plotted vs. 
serotonin concentration. Post-implantation calibration plots are then created and 
utilized to report in vivo concentrations (Figure 2.3D). Post-calibration of each 
electrode is necessary to reliably measure and quantify absolute 
neurotransmitter concentrations, due to the electrode variability (vide supra) and 
ongoing structural changes to the CFM (due to activating potentials > 1.0 V for 
instance) that is encountered in traditional FSCV. A disadvantage to this is that 
lesions cannot be made to histologically identify the CFM placement since the 
electrode needs to remain intact for post calibrations. 
FSCAV was first established for dopamine measurements in vivo in 2015 
and demonstrated it could become a powerful tool used in parallel with FSCV to 
disclose both the phasic and tonic changes in neurotransmitters at a single 
sensor (Atcherley et al., 2015). In 2016, FSCAV was used to record unbound 
Cu2+ in various complex matrices, supporting the ability of FSCAV to and reliably 
perform selective measurements of analytes of interest in numerous fields 
(Pathirathna, Siriwardhane, McElmurry, Morgan, & Hashemi, 2016). More 
recently, ambient measurements of serotonin have been conducted to better 
understand absolute extracellular concentrations of serotonin (Abdalla et al., 
2017; see below). 
2.5 Measurement of the Ambient Extracellular Concentration of Serotonin  
In 2017 ambient measurements of serotonin were established using FSCAV 
(Abdalla et al., 2017). The waveform employed is the above-mentioned Jackson 
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waveform (0.2V to 1.0V to -0.1V to 0.2V; scan rate of 1000 V/s) with a 
supplementary controlled-adsorption period (10s) of a 0.2 V constant potential. 
The third scan after the controlled-adsorption period was extracted for data 
analysis and the integration limits are set approximately from 0.4V to 0.85V, 
encompassing the oxidation peak of serotonin. 
This study reported mouse CA2 hippocampus basal concentration as 64.9 
+ 2.3 nM (Figure 2.4). In comparison, previous microdialysis studies have 
suggested serotonin levels are in a lower nanomolar range (Mathews et al., 
2004; Zhang et al., 2013; Lee et al., 2016). However, FSCAV measurements are 
performed on an entirely different spatial scale due to the fundamentally different 
dimensions of the two probes. Additionally, in FSCAV, the electrode’s position is 
optimized with FSCV and thus located in a “hot spot”, or where there is high 
serotonin activity, which may account for the higher reported serotonin levels. 
After determining basal serotonin levels, the study verified the selectivity of the 
signal in vivo via pharmacology and mathematics. Results showed no 
interference by 5-HIAA, dopamine, or norepinephrine at physiological conditions. 
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Figure 2.4. Ambient measurement of serotonin using fast-scan controlled-
adsorption voltammetry. (A) Representative color plots of serotonin in vivo (i) 
and in vitro (ii). (B). Cyclic voltammograms extracted from the 3rd scan during 
step 3 in (A), shown by dashed, white lines. The inset displays individual (grey) 
and averaged (orange) ambient serotonin recordings from the mouse CA2 region 
of the hippocampus. Reprinted with permission from Abdalla et al., 2017. 
Copyright 2017 American Chemical Society. 
 
The development of FSCAV for serotonin enables the first robust, and 
high-temporal resolution measurements of serotonin’s basal concentrations. 
Coupling FSCAV to FSCV recordings provides a novel platform to acquire a 
deeper chemical understanding of serotonin activity at a single sensor. 
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CHAPTER 3 
A SIMPLIFIED LED-DRIVEN SWITCH FOR FAST-SCAN 
CONTROLLED-ADSORPTION VOLTAMMETRY 
INSTRUMENTATION2
                                                          
2 Robke, R., Hashemi, P., and Ramsson, E. Under Review in HardwareX, 
05/11/2018. 
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Abstract:  
Fast-scan cyclic voltammetry (FSCV) is an analytical tool used to probe 
neurochemical processes in real-time. A major drawback for specialized 
applications of FSCV is that instrumentation must be constructed, or modified, in-
house by those with expertise in electronics. One such specialized application is 
the newly developed fast-scan controlled-adsorption voltammetry (FSCAV), that 
measures ambient in vivo dopamine and serotonin. FSCAV requires additional 
equipment, an operational amplifier coupled to a transistor-transistor logic, which 
was originally termed ‘the switch’, allowing the system to alter between applying 
a FSCV waveform and a constant potential from an external power source to the 
working electrode. To facilitate the integration of FSCAV into existing FSCV 
instruments by making this method more accessible to the community, in this 
paper we design a simplified switching component. Specifically, we employ two 
light emitting diodes (LEDs) to generate the voltage needed to drive a NPN 
bipolar junction transistor, substantially streamlining the circuitry and fabrication 
of the switching component. In vitro and in vivo analyses are performed and 
compared between the new LED circuit vs. the original switch, showing good 
agreement. Thus, we present a new, simplified scheme to perform FSCAV that is 
cheap, simple, and easy to construct by a non-expert.  
 
Keywords: Dopamine, fast-scan cyclic voltammetry, ambient, circuit, 
instrumentation, component 
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Figure 3.1 LED circuit graphical abstract. 
 
 
3.1 Hardware in Context 
Fast-scan controlled-adsorption voltammetry (FSCAV) is a newly developed tool 
that is coupled to existing fast-scan cyclic voltammetry (FSCV) systems to 
measure ambient neurotransmitter concentrations. FSCAV necessitates a 
custom made component, termed the switch, utilizing an operational amplifier 
coupled to a transistor-transistor logic, which may be challenging to those without 
prior experience in electronics. Here, a simplified component, a LED circuit, 
employs two light emitting diodes (LEDs) to generate the voltage needed to drive 
a NPN bipolar junction transistor in a straightforward manner. Hardware 
specifications are shown in Table 3.1. 
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3.2 Hardware Description 
The LED circuit achieves optical isolation of the signal by placing two infrared 
(890nm; 4V forward voltage) LEDs facing one another. Stimulation outputs are 
set at 4V. For digital or TTL pulses, a voltage divider can drop the 5V to the 
necessary 4V, as shown in Figure 3.2A (R1 = 10 kOhm; R2 = 40 kOhm, for 
instance). The light from L1 will illuminate L2 and cause ~0.9V to be generated at 
L2. This is enough to power the base of the NPN BJT transistor and allow the -
0.4V to pass. The output of the circuit is connected to the recording electrode, 
and when the -0.4V is allowed to pass, it clamps the recording electrode at -0.4V. 
The original switch used for FSCAV was constructed in-house and 
connected to existing FSCV systems as an extension of the ‘breakout box’ with 
four connections to an external power supply. The switch utilizes an op amp 
coupled to a TTL, enabling the system to apply the constant potential from the 
external power source (-0.4 V delay). This allows the user to transition between 
FSCV and FSCAV, from stimulation to a constant potential, respectively 
(Atcherley et al., 2013). 
Those without prior electronics training my find it challenging to construct the 
original switch. The new LED circuit described here requires just two infrared 
LEDs and one NPN transistor, enabling this alternative to be cost-effective and 
simple to construct with a basic understanding of soldering principles. The LED 
circuit requires the addition of the external -0.4V power supply through one 
connection, enabling a direct voltage clamp. Additionally, if older FSCV systems 
are utilized, this -0.4V can come from 6052 or 6052e National Instruments cards. 
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The ability to integrate the LED circuit into older FSCV systems is an additional 
advantage of this circuit. The bill of materials can be seen in Table 3.2.  
General points: 
 The LED circuit is a simplified, cheaper version of the original switch 
utilized in FSCAV 
 The LED circuit can be easily coupled to older FSCV existing systems  
 Using the LED circuit, ambient neurotransmitter concentrations can be 
measured with high temporal resolution 
 
3.3 Build Instructions 
 
 Wire the components as shown in the schematic in Figure 3.2A.  
 LED1 (L1) will receive 4V to the anode from a TTL or National 
Instruments card 6052 (6052E) via a female BNC connector. If 
receiving 4V from a TTL, a voltage divider is used to drop the voltage. 
R1 = 10 kOhm; R2 = 40 kOhm. The cathode is connected to ground.  
 The anode of L2 is connected to the base of the NPN transistor. The 
emitter is connected to both the cathode of L2 and an alligator clip or 
terminal. In Figure 3.2B, screws are used as simple terminals, so the -
0.4 V input and Working Electrode output are wired to screws. The 
collector of the NPN transistor will receive the -0.4 V input.  
 The LEDs are shrink-wrapped facing one another and further insulated 
from light by wrapping in electrical tape. This is important as stray light 
can introduce noise.  
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Figure 3.2. Novel LED circuit setup. (A) Simple circuitry scheme of LED 
circuit. (B) Photographic representation of connections. LED lights are 
masked in electrical tape (top) and revealed (bottom). 
 
 
3.4 Operation Instructions  
 
The novel LED circuit scheme is shown in Figure 3.2A, with an external supply 
providing the -0.4V to drive the two LEDs to power a NPN BJT transistor, 
enabling the -0.4V to be applied to the carbon-fiber microelectrode (CFM) 
through an alligator clip. Alternating from the applied waveform to a constant 
potential is under the control of a TTL via a BNC cable. Alternatively, for older 
FSCV existing systems, the -0.4V can come from 6052 or 6052e National 
Instruments cards. The -0.4V power supply, when coming from the NI boards, 
originates from the second analog output (ao1). The first analog output (ao0) is 
utilized for the triangle wave output. A DC task for the -0.4V output can be 
created in National Instruments Automation Explorer. We do not foresee any 
potential safety hazards while setting up or utilizing our described circuit.  
Through the use of FSCV software (WCCV or Demon Voltammetry, for 
example), FSCAV can be employed using the stimulation settings. The pre-event 
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time is set at 2s, the event time at 10s, and the entire file length at 30s. During 
the 10s event time, the LED circuit will act as a voltage clamp that will hold the 
working electrode at a constant potential of -0.4V (or the resting potential of the 
analyte of interest), allowing the analyte to adsorb onto the carbon fiber electrode 
and reach equilibrium with its surroundings (Atcherley et al., 2015; Abdalla et al., 
2017). After file collection, analysis can be done by looking at the first-
background subtracted dopamine cyclic voltammogram (CV) with in-house 
LabVIEW 2012 software. It is important to note that the first-background 
subtracted dopamine CV becomes visible on the 2nd or 3rd scan after the 
waveform is applied after the constant potential of 10s. Due to electrode 
variability, integration limits are set intuitively (Abdalla et al., 2017; Burrell et al., 
2015; Pathirathna et al., 2016).  
 
3.5 Validation and Characterization  
 
In Vitro FSCAV 
To test agreement between FSCAV signals obtained with the switch and the LED 
circuit, a calibration was performed in vitro (n=6 electrodes). Standard solutions 
of dopamine concentrations were prepared by dissolving dopamine hydrochloride 
(Sigma-Aldrich, CO., MO, USA) in Tris-buffer (15 mM H2NC-(CH2)(OH)3·HCl, 140 
mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM NaH2PO4·H2O, 1.2 mM MgCl2, 
and 2.0 mM Na2SO4 at pH = 7.4 in deionized water). A calibration was performed 
using 50, 100, 200, and 500 nM dopamine concentrations using the dopamine 
FSCAV wavefrom (-0.4 V to 1.3 V at 1200 V s-1). These concentrations were 
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previously established to be within the linear calibration range for dopamine 
FSCAV (Atcherley et al. 2015). Either the switch or the LED circuit was first 
utilized to complete a full calibration. The electrode was then cycled in Tris Buffer 
for 10 minutes before the same calibration was performed using the other 
component. The initiating component was altered between separate electrodes 
to reduce biases. 
In Figure 3.3A, representative FSCAV color plots obtained with the LED 
circuit and switch are shown. The color plots contain the voltage (vs. Ag/AgCl) on 
the y-axis, time (30s) on the x-axis, and current (nA) is shown in false color. The 
three steps of FSCAV can be seen. Step 1: the waveform is applied to the 
carbon-fiber microelectrode at high frequency (100 Hz) to minimize adsorption for 
2 seconds (yellow beginning). Step 2: a constant potential being applied for 10 
seconds to allow the neurotransmitter to adsorb, reaching a coverage density in 
equilibrium with the surroundings (black area). Step 3: the waveform is reapplied 
and the adsorbed neurotransmitter is measured in respect to the first step (blue 
event area, noted by the starred, dashed white line). 
To compare measurements, the 3rd scan was utilized in each system 
when a clear, Faradaic dopamine peak was visible. Figure 3.3B shows the 
respective current trace of the 3rd scan for the LED circuit (orange) and switch 
(blue) with current on the y-axis and time in milliseconds on the x-axis. The 
dashed lines note integration limits, or where the area under the curve was 
calculated, for the quantification of dopamine for each system. Figure 3.3C is the 
resulting calibration plot of the LED circuit and switch with charge (pC) on the y-
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axis and concentration (nM) on the x-axis. Both systems show good agreement 
in their measurements with no statistical difference from 50 to 500 nM of 
dopamine (n=6; p > 0.05 for all concentrations), consistent with expected in vivo 
concentrations (Atcherley et al. 2013). 
Figure 3.3. LED Circuit vs. Switch in vitro measurement comparison. (A) 
Representative color plots of the LED circuit (top) and switch (bottom) in vitro. (B) 
Extracted cyclic voltammograms for the LED circuit (orange) and switch (blue) 
from dashed, starred line in A. (C) Calibration plot comparison of the LED circuit 
and switch, showing good agreement in their measurements (n=6) + SEM. 
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In Vivo FSCAV 
After validating that the switch and the LED circuit enable statistically identical 
FSCAV measurements in vitro, we moved to comparisons of in vivo responses. 
In vivo dopamine measurements were performed in the nucleus accumbens core 
(NAcc), a brain locality rich in dopamine terminals (Nirenberg et al., 1997; 
Meredith et al., 1992). First, to verify that the electrode was correctly placed in 
the NAcc, stimulation of the medial forebrain bundle (MFB) was used to confirm 
the release of dopamine with FSCV using a triangular waveform (-0.4V to 1.3V at 
400 V s-1). Handling and surgery of 3 male C57BL/6J mice weighing 20-25 g 
(Jackson Laboratory, Bar Harbor, ME) were in agreement with The Guide for the 
Care and Use of Laboratory Animals and approved by the Institutional Animal 
Care Use Committee. Urethane (25% dissolved in 0.9% NaCl solution, Hospira, 
Lake Forest, IL) was administered via intraperitoneal (i.p.) injection and 
stereotaxic surgery (David Kopf Instruments, Tujunga, CA) was performed. A 
heating pad sustained mouse body temperature around 37°C (Braintree 
Scientific, Braintree, MA). Stereotaxic coordinates were taken in reference to 
bregma. A Nafion modified CFM was inserted into the nucleus accumbens core 
(NAcc) (AP: +1.09, ML: -1.25, DV: -4.30). 120 Biphasic pulses were applied 
through a linear constant current stimulus isolator (NL800A, Neurolog, Medical 
Systems Corp., Great Neck, NY). An Ag/AgCl reference electrode was implanted 
into the brain’s opposite hemisphere.  
Figure 3.4A (top left) displays the experimental scheme, noting the 
working electrode in the NAcc and the stimulating electrode in the MFB. Figure 
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3.4B shows the in vivo FSCV color plot, in which the green event denotes the 
release of dopamine by stimulation (grey bar below – 2 second duration). 
Dopamine is confirmed by its distinctive cyclic voltammogram; oxidation at 0.6 V 
and reduction at -0.2 V (white inset taken from the vertical, dashed white line).  
Next, the dopamine FSCAV waveform was applied to the working 
electrode and the two FSCAV components compared. The components used to 
obtain initial in vivo measurements were altered between animals. Figure 3.4C 
shows the LED circuit in vivo color plot and corresponding current trace for the 
3rd scan, shown by the star and dashed, white line. The integration limits are set 
by first placing the final limit where a stable minimum can be found after the 
oxidative peak, and then lining up the cross hairs of the initial limit to the final 
(Figure 3.4C). It is important to note that the 2nd scan could not be taken for the 
LED circuit, as the background, governed by capacitative current, was large 
enough (~600 nA) to mask the Faradaic peaks, because of the presence of 
additional adsorbing analytes in vivo or more likely stray capacitance from the 
BJT transistor. In Figure 3.4D, a color plot and current trace are shown for the 
original switch. For the switch’s integration limits, we utilize the 2nd scan, as 
previously published (Atcherley et al., 2015), instead of the 3rd scan, which is 
shown by the star and white dashed line. While this scan has a large, non-
Faradaic background peak (~350 nA), most importantly, the 2nd scan has the first 
clearly distinguishable Faradaic dopamine peak.  
The original work on FSCAV with the switch performed convolution prior to 
analysis (Atcherley et al., 2013; Atcherley et al., 2014), however, it has since 
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been shown that convolution is not always required (Abdalla et al. 2017; Burrell 
et al. 2015; Pathirathna et al., 2016). We did not employ convolution data 
analysis to our results. The switch’s integration limits are set by placing both 
initial and final limits at the local minima, and encompassing the entire peak. It is 
important to note that the integration limits in vivo were altered from the previous 
in vitro comparison of both systems to account for the complex matrix of the brain 
and additional analytes that are present (Takmakov et al., 2010b; Cahill et al., 
1996; Heien et al., 2004). A post-calibration was performed on the experimental 
electrodes using 50, 100, 200, and 500 nM dopamine concentrations.  
Using the same calibration concentrations and procedure as the in vitro 
experiment, the resulting in vivo dopamine concentration for the switch = 95.0 + 
11.0 nM and the novel LED circuit = 94.4 + 7.0 nM. These values are statistically 
identical and in good agreement with values that we previously published 
(Atcherley et al., 2015) (n=3; p = 0.96). 
As a final characterization, the root-mean-square of the signal and noise in 
the in vivo recordings was calculated. For a direct comparison, using the 3rd scan 
for both the LED circuit and switch, we found a signal to noise ratio (S/N) of 
281.7 and 199.5, respectively. Furthermore, to compare the scans we used for 
the in vivo analysis above, we performed the same RMS calculation for the 3rd 
scan of the LED circuit vs. the 2nd scan for the switch. The resulting S/N was 
281.7 for the LED circuit and 562.6 for the switch.  It is important to note that 
during the 2nd scan for the switch, there is a large background peak which 
contributes to the signal, as shown in the IT curve in Figure 3.4D. However, as 
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previously mentioned, since the first, clear dopamine peak is also obtained 
during the 2nd scan, it is feasible to obtain in vivo concentrations of dopamine. 
The BJT transistor, utilized by the LED circuit, takes longer to not only shut off, 
but may add stray capacitance that appears as additional background in scan 2. 
The CMOS precision switch has a much faster switching capability, enabling the 
dopamine peak to already appear by the 2nd scan. Nonetheless, it is necessary to 
point out that the direct comparison of the 3rd scan shows a higher S/N for the 
LED circuit, indicating it has more favorable recording capabilities in vitro. 
Additionally, the LED circuit provides high enough S/N for in vivo measures with 
accurate results. 
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Figure 3.4. LED Circuit vs. Switch in vivo measurement comparison. (A) 
Experimental scheme of in vivo experiments in the mouse brain. (B) FSCV 
verification recording of dopamine release in the nucleus accumbens core after 
electrical stimulation of the medial forebrain bundle. (C) LED circuit color plot and 
extracted cyclic voltammogram from the dashed, starred line (3rd scan). (D) 
Switch color plot and extracted cyclic voltammogram from the dashed, starred 
line (2nd scan). Integration limits are shown in black, dashed lines.  
 
 
 
 
 
 
 
 
 
 
 
 51 
Table 3.1 LED Circuit Hardware Specifications 
 
Hardware name LED Circuit 
Subject area  Chemistry and Biochemistry 
 Neuroscience 
 Biological Sciences (e.g. Microbiology and 
Biochemistry) 
Hardware type  Field measurements and sensors 
 Voltammetry 
Open Source License Creative Commons Attribution-ShareAlike 3.0 
Cost of Hardware ~$5.00 
Source File Repository N/A – design included in body of manuscript 
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Table 3.2 LED Circuit Bill of Materials 
  
Designator Component  # Cost per unit 
-currency 
Total cost - 
currency 
Source of 
materials 
Material 
type 
LED OP295A 
Infrared 890nm LED 
2 $0.75 $1.50 Mouser 
Electronics 
N/A  
NPN Bipolar 
Transistor 
BC548CTA  
NPN 30V 100mA 
1 $0.20 $0.20 Mouser 
Electronics 
N/A 
BNC 
connector 
565-6741 
BNC female 
1 $3.49 $3.49 Mouser 
Electronics 
N/A 
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CHAPTER 4 
CONCLUSIONS AND PROSPECTS
 54 
 
Serotonin is an important biomolecule and key regulator in many neurochemical 
pathways. However, a precise definition of normal and irregular serotonin 
neurotransmission has yet to be determined due to the lack of tools that can 
detect serotonin on a relevant timescale in vivo. This thesis has described the 
most recent work done to characterize serotonin’s synaptic activity and elucidate 
this transmitter’s distinct function using novel electrochemical techniques. 
 This thesis addressed the historical challenges of selectively targeting and 
measuring serotonin and highlighted FSCV as a powerful electroanalytical 
technique that able to overcome these obstacles in order to better understand 
phasic-release serotonin dynamics. Furthermore, FSCAV technology has 
allowed for the first rapid measurement of ambient neurotransmitter 
concentrations (Chapter 2). In Chapter 3, simplified instrumentation for fast-
voltammetric analysis was developed and characterized to allow non-experts in 
electronics and electrochemistry to utilize FSCAV.  
To better understand in vivo serotonin dynamics, an innovative platform is 
needed to measure serotonin dynamics during real-time environmental stimuli 
and behavior. FSCV measurement of serotonin in freely-moving animals would 
provide critical information on: 
a. the underlying processes that serotonin encodes 
b. which environmental stimuli induce serotonin release 
c. how serotonin events are time-locked to behavioral events on a  
physiologically relevant time scale (10 Hz) 
d. regional differences in the brain for a) - c) 
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These topics are routinely studied via dopamine FSCV (Klanker, Feenstra, 
Willuhn, & Denys, 2017; Howe, Tierney, Sandberg, Phillips, & Graybiel, 2013). 
Therefore, given the development of suitable tools, it is feasible to address these 
questions for serotonin as well. It is foreseeable that the concentrations of 
evoked serotonin would differ in freely moving vs. anesthetized animals due to 
serotonin’s role in circadian rhythms and heightened activity during wakefulness 
(Penalva et al., 2003). As a result, even though evoked serotonin levels in 
anesthetized animals are low, it is expected that these concentrations may be 
higher in freely moving animals. 
 Currently, all serotonin FSCV experiments utilize acute, glass electrodes 
which are lowered the day of electrochemical recording. Due to damage and 
stress of implanting the electrode for the animal, it is not recommended to do this 
procedure more than once in an individual animal. Thus, chronically implanted 
electrodes for serotonin would greatly aide behavior studies so that serotonin 
measurements could be conducted for longer periods of time during the evolution 
of behavior such as addiction, depression or compulsivity (Clark et al., 2010; 
Rodeberg, Sandberg, Johnson, Phillips, & Wightman, 2017). 
It will also be of critical importance to record tonic extracellular serotonin in 
different disease states, such as depression, to explore whether or not ambient 
serotonin levels influence the development, maintenance, or reversal of 
neuropsychiatric disorders. The LED circuit was constructed for novices in 
electronics and electrochemistry, thus skilled neuroscientists can now utilize this 
new technology to measure ambient serotonin in any respective animal model.  
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Furthermore, with respect to the rise of novel genetics-based tools for specific 
manipulation (i.e. optogenetics and chemogenetics) and execution in mice, 
FSCV would act as a neurochemical readout to verify the selectivity of the 
manipulation. The coupling of genetic manipulation and serotonin FSCV would 
also greatly improve our knowledge of serotonin activity and influences on 
behavior, mood, and other neuronal systems. Although these methods are 
beginning to be executed in mice, it is crucial to obtain a neurochemical readout 
via FSCV to verify the selectivity of the manipulation. Overall, there are still many 
questions about serotonergic mechanisms governing healthy brain function that 
remain unanswered. Exciting new developments in fast-voltammetric techniques 
mean that the scientific community is one step closer to unraveling the function of 
this elusive neurotransmitter. 
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